Shares of Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC – Get Free Report) traded up 3.1% during mid-day trading on Monday . The stock traded as high as $28.64 and last traded at $28.64. 2,262 shares changed hands during trading, a decline of 38% from the average session volume of 3,630 shares. The stock had previously closed at $27.78.
Virtus LifeSci Biotech Clinical Trials ETF Stock Performance
The company’s 50 day moving average price is $26.69 and its 200-day moving average price is $27.08.
Virtus LifeSci Biotech Clinical Trials ETF Company Profile
The Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. BBC was launched on Dec 16, 2014 and is managed by Virtus.
